Drug makers to add TEN, SJS in package insert of Ciprofloxacin: CDSCO panel
The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may request State Drugs Controllers to direct the manufacturers of Ciprofloxacin to incorporate drug associated Stevens-Johnson Syndrome (SJS) / Toxic Epidermal Necrolysis (TEN) in the package insert of the drug.
This came in line with the recommendation of the signal review panel, Pharmacovigilance Programme of India (PvPI), and the Indian Pharmacopoeia Commission (IPC), which was placed before the committee.
For more information, check out the full story on the link below:
Drug makers to add SJS, TEN in package insert of Ciprofloxacin: CDSCO panel
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd